Evonik opens new facility for pharmaceutical lipids in Germany

New GMP facility for clinical and small-scale commercial pharmaceutical lipids

Lonza upgrades powder characterization capabilities at Tampa

The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation

Evonik partners with AMSilk to manufacture sustainable silk proteins

Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials

Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging

Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event

NATCO launches generic Pomalidomide Capsules in Canada

Natco launched pomalidomide under their brand NAT-POMALIDOMIDE in strengths of 1 mg, 2 mg, 3 mg and 4 mg capsules

Alembic gets USFDA final approval for ANDA Docetaxel Injection

Venus Remedies awarded Saudi GMP approval for all its production facilities in Baddi

The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region

No link between the use of ranitidine and cancer risk, claims Nature

N-nitroso dimethylamine (NDMA) is a probable human carcinogen and tts effects on humans rely on observational studies.

MEI Pharma and Infinity Pharmaceuticals inks merger agreement to advance three promising clinical oncology candidates

Projected ~US$100 million cash balance of combined company expected to fund operations through mid-2025 and to clinical data over the next 12 to 24 months

Moderna and Merck announce investigational personalized cancer vaccine mRNA-4157/V940

Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial